Abstract
The increasing survival to adulthood of patients with congenital heart disease (CHD) has changed the epidemiology of adult CHD (ACHD) patients and has led to an increment in hospitalization rates due to heart failure (HF). ACHD patients hospitalized for HF have a five-fold higher risk of death than those compensated. HF occurs predominantly in patients with tetralogy of Fallot, single ventricles, and after the Mustard operation for transposition of the great arteries. Diagnostic strategies applied in acquired HF patients are usually used to evaluate ACHD patients, but sometimes this can postpone the identification of HF that can become manifest with unusual and peculiar signs or symptoms. In the same way, therapeutic management resembles the acquired HF one, even if no large randomized clinical trials have been conducted in ACHD patients. Therefore, a close monitoring in dedicated units is mandatory in order to identify in time HF manifestations and manage them adequately.
| Original language | English |
|---|---|
| Pages (from-to) | 329-336 |
| Number of pages | 8 |
| Journal | Minerva Cardioangiologica |
| Volume | 66 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 1 2018 |
Fingerprint
Keywords
- Adult.
- Congenital heart defects
- Heart failure
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Heart failure in grown-up congenital heart disease. / Faccini, Alessia; Micheletti, Angelo; Negura, Diana G.; Giugno, Luca; Butera, Gianfranco; Carminati, Mario; Giamberti, Alessandro; Chessa, Massimo.
In: Minerva Cardioangiologica, Vol. 66, No. 3, 01.06.2018, p. 329-336.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Heart failure in grown-up congenital heart disease
AU - Faccini, Alessia
AU - Micheletti, Angelo
AU - Negura, Diana G.
AU - Giugno, Luca
AU - Butera, Gianfranco
AU - Carminati, Mario
AU - Giamberti, Alessandro
AU - Chessa, Massimo
PY - 2018/6/1
Y1 - 2018/6/1
N2 - The increasing survival to adulthood of patients with congenital heart disease (CHD) has changed the epidemiology of adult CHD (ACHD) patients and has led to an increment in hospitalization rates due to heart failure (HF). ACHD patients hospitalized for HF have a five-fold higher risk of death than those compensated. HF occurs predominantly in patients with tetralogy of Fallot, single ventricles, and after the Mustard operation for transposition of the great arteries. Diagnostic strategies applied in acquired HF patients are usually used to evaluate ACHD patients, but sometimes this can postpone the identification of HF that can become manifest with unusual and peculiar signs or symptoms. In the same way, therapeutic management resembles the acquired HF one, even if no large randomized clinical trials have been conducted in ACHD patients. Therefore, a close monitoring in dedicated units is mandatory in order to identify in time HF manifestations and manage them adequately.
AB - The increasing survival to adulthood of patients with congenital heart disease (CHD) has changed the epidemiology of adult CHD (ACHD) patients and has led to an increment in hospitalization rates due to heart failure (HF). ACHD patients hospitalized for HF have a five-fold higher risk of death than those compensated. HF occurs predominantly in patients with tetralogy of Fallot, single ventricles, and after the Mustard operation for transposition of the great arteries. Diagnostic strategies applied in acquired HF patients are usually used to evaluate ACHD patients, but sometimes this can postpone the identification of HF that can become manifest with unusual and peculiar signs or symptoms. In the same way, therapeutic management resembles the acquired HF one, even if no large randomized clinical trials have been conducted in ACHD patients. Therefore, a close monitoring in dedicated units is mandatory in order to identify in time HF manifestations and manage them adequately.
KW - Adult.
KW - Congenital heart defects
KW - Heart failure
UR - http://www.scopus.com/inward/record.url?scp=85047721770&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047721770&partnerID=8YFLogxK
U2 - 10.23736/S0026-4725.18.04591-7
DO - 10.23736/S0026-4725.18.04591-7
M3 - Review article
C2 - 29327893
AN - SCOPUS:85047721770
VL - 66
SP - 329
EP - 336
JO - Minerva Cardioangiologica
JF - Minerva Cardioangiologica
SN - 0026-4725
IS - 3
ER -